| Assessment Status | Rapid Review Complete |
| HTA ID | - |
| Drug | Pegylated Interferon beta-1a |
| Brand | Plegridy® |
| Indication | Treatment of adult patients with relapsing remitting multiple sclerosis |
| Assessment Process | |
| Rapid review commissioned | 25/11/2014 |
| Rapid review completed | 22/12/2014 |
| Rapid review outcome | Full Pharmacoeconomic Assessment Not Recommended |